Search research articles
Contact Us
Filters
Showing results (11-20 of 14) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 14 results.
Nature Communications
|
April 24, 2024
Publisher Correction: Semaphorin 3A causes immune suppression by inducing cytoskeletal paralysis in tumour-specific CD8<sup>+</sup> T cells
Mike B Barnkob, Yale S Michaels, Violaine André, et al.
Nature Communications
|
November 8, 2023
Single cell spatial analysis reveals inflammatory foci of immature neutrophil and CD8 T cells in COVID-19 lungs
Praveen Weeratunga, Laura Denney, Joshua A Bull, et al.
Nature Communications
|
April 12, 2024
Semmaphorin 3 A causes immune suppression by inducing cytoskeletal paralysis in tumour-specific CD8<sup>+</sup> T cells
Mike B Barnkob, Yale S Michaels, Violaine André, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 18, 2021
Mitochondrial Inhibitor Atovaquone Increases Tumor Oxygenation and Inhibits Hypoxic Gene Expression in Patients with Non-Small Cell Lung Cancer
Michael Skwarski, Daniel R McGowan, Elizabeth Belcher, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 14) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 14 results.
Nature Communications
|
April 24, 2024
Publisher Correction: Semaphorin 3A causes immune suppression by inducing cytoskeletal paralysis in tumour-specific CD8<sup>+</sup> T cells
Mike B Barnkob, Yale S Michaels, Violaine André, et al.
Nature Communications
|
November 8, 2023
Single cell spatial analysis reveals inflammatory foci of immature neutrophil and CD8 T cells in COVID-19 lungs
Praveen Weeratunga, Laura Denney, Joshua A Bull, et al.
Nature Communications
|
April 12, 2024
Semmaphorin 3 A causes immune suppression by inducing cytoskeletal paralysis in tumour-specific CD8<sup>+</sup> T cells
Mike B Barnkob, Yale S Michaels, Violaine André, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 18, 2021
Mitochondrial Inhibitor Atovaquone Increases Tumor Oxygenation and Inhibits Hypoxic Gene Expression in Patients with Non-Small Cell Lung Cancer
Michael Skwarski, Daniel R McGowan, Elizabeth Belcher, et al.
Page
of 2